Ascentage Pharma Group International (AAPG) Accumulated Expenses: 2023-2025
- Ascentage Pharma Group International's Accumulated Expenses was N/A to -$5.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.6 billion, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is 100.04% up from last year.
- Latest data reveals that Ascentage Pharma Group International reported Accumulated Expenses of -$5.6 billion as of Q2 2025, which was down 273,288.51% from $2.0 million recorded in Q4 2024.
- Over the past 5 years, Ascentage Pharma Group International's Accumulated Expenses peaked at $2.0 million during Q4 2024, and registered a low of -$5.6 billion during Q2 2025.
- In the last 3 years, Ascentage Pharma Group International's Accumulated Expenses had a median value of $568,049 in 2023 and averaged -$1.9 billion.
- Data for Ascentage Pharma Group International's Accumulated Expenses shows a peak YoY soared of 258.07% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Ascentage Pharma Group International's Accumulated Expenses stood at $568,049 in 2023, then skyrocketed by 258.07% to $2.0 million in 2024, then reached -$5.6 billion in 2025.
- Its Accumulated Expenses was -$5.6 billion in Q2 2025, compared to $2.0 million in Q4 2024 and $568,049 in Q4 2023.
